Cargando…
Myelofibrosis and Pancytopenia Associated With Primary Hyperparathyroidism
OBJECTIVE: Primary hyperparathyroidism (PHPT) has varied clinical presentations. Hematologic abnormalities secondary to PHPT have been described before. However, pancytopenia as the initial presentation has rarely been reported. We report a patient with PHPT who presented for evaluation of pancytope...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association of Clinical Endocrinology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924162/ https://www.ncbi.nlm.nih.gov/pubmed/33851024 http://dx.doi.org/10.1016/j.aace.2020.11.018 |
_version_ | 1783659032904466432 |
---|---|
author | Rajan, Remya Paul, Immanuel Cherian, Kripa Elizabeth Korula, Anu Hephzibah, Julie Manipadam, Marie Therese Abraham, Deepak Thomas Kapoor, Nitin Paul, Thomas Vizhalil |
author_facet | Rajan, Remya Paul, Immanuel Cherian, Kripa Elizabeth Korula, Anu Hephzibah, Julie Manipadam, Marie Therese Abraham, Deepak Thomas Kapoor, Nitin Paul, Thomas Vizhalil |
author_sort | Rajan, Remya |
collection | PubMed |
description | OBJECTIVE: Primary hyperparathyroidism (PHPT) has varied clinical presentations. Hematologic abnormalities secondary to PHPT have been described before. However, pancytopenia as the initial presentation has rarely been reported. We report a patient with PHPT who presented for evaluation of pancytopenia. METHODS: Histopathology of the bone marrow at presentation is described. Bone biochemistry results and the hematologic profile before and after curative parathyroidectomy are presented. RESULTS: A 48-year-old woman presented with pancytopenia (hemoglobin, 6.3 g/dL; total leucocyte count, 3000 cells/mm(3); and platelet count, 60 000 cells/mm(3)), and her bone marrow study showed marrow fibrosis. Biochemical evaluation revealed hypercalcemia (15.5 mg/dL), hypophosphatemia (2.2 mg/dL), and elevated total alkaline phosphatase (4132 U/L). Bone mineral density assessment by dual-energy X-ray absorptiometry scan revealed osteoporosis at all 3 sites, which was more severe in the distal one third of the forearm. Further investigations confirmed the diagnosis of PHPT (serum parathyroid hormone, 2082 pg/mL). Following curative parathyroidectomy, in addition to normalization of calcium, there was restoration of all 3 hematologic cell lines at 3 months. CONCLUSION: Pancytopenia may be a rare manifestation of PHPT. Thus, it may be prudent to evaluate the calcium profile in patients with chronic refractory anemia and pancytopenia. |
format | Online Article Text |
id | pubmed-7924162 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | American Association of Clinical Endocrinology |
record_format | MEDLINE/PubMed |
spelling | pubmed-79241622021-04-12 Myelofibrosis and Pancytopenia Associated With Primary Hyperparathyroidism Rajan, Remya Paul, Immanuel Cherian, Kripa Elizabeth Korula, Anu Hephzibah, Julie Manipadam, Marie Therese Abraham, Deepak Thomas Kapoor, Nitin Paul, Thomas Vizhalil AACE Clin Case Rep Case Report OBJECTIVE: Primary hyperparathyroidism (PHPT) has varied clinical presentations. Hematologic abnormalities secondary to PHPT have been described before. However, pancytopenia as the initial presentation has rarely been reported. We report a patient with PHPT who presented for evaluation of pancytopenia. METHODS: Histopathology of the bone marrow at presentation is described. Bone biochemistry results and the hematologic profile before and after curative parathyroidectomy are presented. RESULTS: A 48-year-old woman presented with pancytopenia (hemoglobin, 6.3 g/dL; total leucocyte count, 3000 cells/mm(3); and platelet count, 60 000 cells/mm(3)), and her bone marrow study showed marrow fibrosis. Biochemical evaluation revealed hypercalcemia (15.5 mg/dL), hypophosphatemia (2.2 mg/dL), and elevated total alkaline phosphatase (4132 U/L). Bone mineral density assessment by dual-energy X-ray absorptiometry scan revealed osteoporosis at all 3 sites, which was more severe in the distal one third of the forearm. Further investigations confirmed the diagnosis of PHPT (serum parathyroid hormone, 2082 pg/mL). Following curative parathyroidectomy, in addition to normalization of calcium, there was restoration of all 3 hematologic cell lines at 3 months. CONCLUSION: Pancytopenia may be a rare manifestation of PHPT. Thus, it may be prudent to evaluate the calcium profile in patients with chronic refractory anemia and pancytopenia. American Association of Clinical Endocrinology 2020-12-28 /pmc/articles/PMC7924162/ /pubmed/33851024 http://dx.doi.org/10.1016/j.aace.2020.11.018 Text en © 2020 AACE. Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Rajan, Remya Paul, Immanuel Cherian, Kripa Elizabeth Korula, Anu Hephzibah, Julie Manipadam, Marie Therese Abraham, Deepak Thomas Kapoor, Nitin Paul, Thomas Vizhalil Myelofibrosis and Pancytopenia Associated With Primary Hyperparathyroidism |
title | Myelofibrosis and Pancytopenia Associated With Primary Hyperparathyroidism |
title_full | Myelofibrosis and Pancytopenia Associated With Primary Hyperparathyroidism |
title_fullStr | Myelofibrosis and Pancytopenia Associated With Primary Hyperparathyroidism |
title_full_unstemmed | Myelofibrosis and Pancytopenia Associated With Primary Hyperparathyroidism |
title_short | Myelofibrosis and Pancytopenia Associated With Primary Hyperparathyroidism |
title_sort | myelofibrosis and pancytopenia associated with primary hyperparathyroidism |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924162/ https://www.ncbi.nlm.nih.gov/pubmed/33851024 http://dx.doi.org/10.1016/j.aace.2020.11.018 |
work_keys_str_mv | AT rajanremya myelofibrosisandpancytopeniaassociatedwithprimaryhyperparathyroidism AT paulimmanuel myelofibrosisandpancytopeniaassociatedwithprimaryhyperparathyroidism AT cheriankripaelizabeth myelofibrosisandpancytopeniaassociatedwithprimaryhyperparathyroidism AT korulaanu myelofibrosisandpancytopeniaassociatedwithprimaryhyperparathyroidism AT hephzibahjulie myelofibrosisandpancytopeniaassociatedwithprimaryhyperparathyroidism AT manipadammarietherese myelofibrosisandpancytopeniaassociatedwithprimaryhyperparathyroidism AT abrahamdeepakthomas myelofibrosisandpancytopeniaassociatedwithprimaryhyperparathyroidism AT kapoornitin myelofibrosisandpancytopeniaassociatedwithprimaryhyperparathyroidism AT paulthomasvizhalil myelofibrosisandpancytopeniaassociatedwithprimaryhyperparathyroidism |